Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PTX3 Genetically Stratified Randomized Double-blinded Allocation Event-driven Clinical Trial for Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia

NCT03828773 is registered in ClinicalTrials.gov with Bochud Pierre-Yves as lead sponsor.

NCT NCT03828773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03828773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PTX3 Genetically Stratified Randomized Double-blinded Allocation Event-driven Clinical Trial for Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia
Lead sponsor
Bochud Pierre-Yves
Phase
Not applicable
Overall status
Recruiting
Start date
February 11, 2019
Completion date
November 30, 2027
Enrollment
410 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, aspergillosis, candidiasis, fungal infection, genetic predisposition